Peptides having anti-inflammatory properties
Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the peptides to treat conditions associated with excessive inflammation in animals, particularly humans and other mammals.
1. An immunomodulatory peptide of 18 amino acid residues or less in length, wherein the peptide has a sequence defined by one of the formulae:
[Y 1a Y 1b ]-[X 1a X 1b ]-[Y 2a Y 2b ]-[X 2a X 2b ]-[Y 3a ]-[X 3a ]; and
[X 3a ]-[Y 3a ]-[X 2b X 2a ]-[Y 2b Y 2a ]-[X 1b X 1a ]-[Y 1b Y 1a ];
wherein:
Y 1a , Y 1b , Y 2a , Y 2b and Y 3a are each phenylalanine; and
X 1a , X 1b , X 2a , X 2b and X 3a are each independently selected from lysine and arginine.
2. The immunomodulatory peptide according to claim 1 , wherein the striapathic region of the peptide has a length of 12 amino acid residues or less.
3. The immunomodulatory peptide according to claim 1 , wherein the peptide comprises the amino acid sequence FFKKFFKKFK (SEQ ID NO:123).
4. The immunomodulatory peptide according to claim 2 , wherein the peptide consists essentially of the amino acid sequence FFKKFFKKFK (SEQ ID NO:123).
5. The immunomodulatory peptide according to claim 1 , wherein the peptide comprises the amino acid sequence KFKKFFKKFF (SEQ ID NO:124).
6. The immunomodulatory peptide according to claim 2 , wherein the peptide consists essentially of the amino acid sequence KFKKFFKKFF (SEQ ID NO:124).
7. An immunomodulatory peptide of 18 amino acid residues or less in length, the peptide comprising the amino acid sequence KFKKAFKKAF (SEQ ID NO:148) or FFRKFAKRFK (SEQ ID NO:122).
8. The immunomodulatory peptide according to claim 7 , wherein the peptide consists essentially of the amino acid sequence KFKKAFKKAF (SEQ ID NO:148).
9. The immunomodulatory peptide according to claim 7 , wherein the peptide consists essentially of the amino acid sequence FFRKFAKRFK (SEQ ID NO:122).